Neonatal heel prick mass spectrometry identifies metabolic predictors of AML latency
Date
2021
Authors
Lim, K.
Thompson-Peach, C.
Thomas, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Leukemia Research, 2021; 109:1-3
Statement of Responsibility
Kelly Lim, Chloe Thompson-Peach, Daniel Thomas
Conference Name
Abstract
Ongoing research efforts that consider cancer as a disease of dramatically altered cellular metabolism have accelerated interest in snapshot metabolomics in various human tissues. In this issue of Leukemia Research, Petrick et al performed metabolomic analysis on newborn blood spots and found a number of unexpected ceramide and sphingolipid compounds that may play a role in the development and latency of pediatric acute myeloid leukemia (AML). The chemical complexity and range of cellular metabolites massively exceeds the relatively limited building blocks of the transcriptome or the proteome and has high potential to find novel leukemia-specific macromolecular synthesis pathways, metabolic vulnerabilities and biomarkers.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2021 Elsevier Ltd. All rights reserved.